journal article·2025-12-22Open access

Synergistic Effect of Conditioned Medium and Calcium Phosphate Biocement on Osteogenic Properties of Composite

Mária Giretová, Ľubomír Medvecký, Lenka Luptáková, Radoslava Štulajterová, Tibor Sopčák, Eva Székiová

Abstract

The aim of the study was to investigate the synergistic effect of conditioned medium (CM) and two types of calcium phosphate biocements on the osteogenic properties of a composite material through rat bone marrow-derived mesenchymal stem cells (MSCs). Briefly, MSCs were cultured for 7 and 17 days in extracts derived from the two biocement types. These extracts were supplemented with 5% (v/v) of concentrated CM. The CM was obtained from rat bone marrow MSC cultures after a 48 h conditioning period. The results showed that the addition of CM had a significant positive impact on the osteoblastic differentiation of MSCs, particularly in the extracts from the tetracalcium phosphate/monetite/calcium sulfate hemihydrate biocement (designated as CAS cement) compared to the other tested cement extract (designated C cement). After 17 days of culturing, a notable increase in cell viability and alkaline phosphatase (ALP) activity, as well as the upregulation of osteoblastic-related gene expression, was found. This enhancement in osteogenic activity was likely driven by the growth factors and bioactive molecules present in the CM. The study concluded that supplementing the biocement extracts with only 5% of 10X concentrated CM is sufficient to significantly influence and improve the in vitro characteristics, cell behavior, gene expression, and synthesis of cell products. It was demonstrated that, especially in the CAS supplemented with CM (CAS + CM) extract system, the improvement in osteogenic properties was due to the synergistic effect between the higher concentration of calcium ions in extracts released from the calcium sulfate hemihydrate-containing cement and the bioactive molecules supplied by the CM.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Endodontics and Root Canal Treatments · Alkaline Phosphatase Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Functional and Hybrid Materials, Institute of Materials Research of Slovak Academy of Sciences, Watsonova 47, 040 01 Košice, Slovakia

Department of Biology and Physiology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia

Institute of Neurobiology of Biomedical Research Center, Slovak Academy of Sciences, Šoltesovej 4–6, 040 01 Košice, Slovakia

Funding

Slovak Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences

References (56)

Show source-provided references
1. Effect of microstructure characteristics on tetracalcium phosphate–nanomonetite cement in vitro cytotoxicity10.1088/1748-6041/10/2/025006 ↗
2. Varga, M., Kresakova, L., Danko, J., Vdoviakova, K., Humenik, F., Rusnak, P., Giretova, M., Spakovska, T., Andrejcakova, Z., and Kadasi, M. (2023). Tetracalcium Phosphate Biocement Hardened with a Mixture of Phytic Acid–Phytase in the Healing Process of Osteochondral Defects in Sheep. Int. J. Mol. Sci., 24.10.3390/ijms242115690 ↗
3. Medvecky, L., Giretova, M., Stulajterova, R., Danko, J., Vdoviakova, K., Kresakova, L., Zert, Z., Petrovova, E., Holovska, K., and Varga, M. (2021). Characterization of Properties, In Vitro and In Vivo Evaluation of Calcium Phosphate/Amino Acid Cements for Treatment of Osteochondral Defects. Materials, 14.10.3390/ma14020436 ↗
4. Effectiveness of mesenchymal stem cell-conditioned medium in bone regeneration in animal and human models: A systematic review and meta-analysis10.1186/s13619-020-00047-3 ↗
5. Comparative evaluation of different crystal-structured calcium sulfates as bone-filling materials10.1002/jbm.b.31428 ↗
6. Tissue reaction and material biodegradation of a calcium sulfate/apatite biphasic bone substitute in rat muscle10.1016/j.jot.2015.11.002 ↗
7. Ferraz, M.P. (2024). An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells. Int. J. Mol. Sci., 25.10.3390/ijms25073836 ↗
8. Mesenchymal stem cells: Clinical applications and biological characterization10.1016/j.biocel.2003.11.001 ↗
9. Are Stem Cells the Magical Medical Therapy of the Future?10.1016/S1016-3190(09)60003-3 ↗
10. Uncovering the secretes of mesenchymal stem cells10.1016/j.biochi.2013.06.017 ↗
11. Sagaradze, G., Grigorieva, O., Nimiritsky, P., Basalova, N., Kalinina, N., Akopyan, Z., and Efimenko, A. (2019). Conditioned Medium from Human Mesenchymal Stromal Cells: Towards the Clinical Translation. Int. J. Mol. Sci., 20.10.3390/ijms20071656 ↗
12. Giuliani, A., Sena, G., Tromba, G., Mazzon, E., Fontana, A., Diomede, F., Piattelli, A., and Trubiani, O. (2020). Could the Enrichment of a Biomaterial with Conditioned Medium or Extracellular Vesicles Modify Bone-Remodeling Kinetics during a Defect Healing? Evaluations on Rat Calvaria with Synchrotron-Based Microtomography. Appl. Sci., 10.10.3390/app10072336 ↗
13. Characterisation of mesenchymal stem cells conditioned media obtained at different conditioning times: Their effect on glial cells in in vitro scratch model10.1080/08977194.2023.2182145 ↗
14. 3D-Printed Poly(-caprolactone) Scaffold Augmented with Mesenchymal Stem Cells for TotalMeniscal Substitution: A 12- and 24-Week Animal Study in a Rabbit Model10.1177/0363546517691513 ↗
15. Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetes Mellitus Rats10.48048/tis.2024.7278 ↗
16. Clinical Study of Bone Regeneration by Conditioned Medium from Mesenchymal Stem Cells After Maxillary Sinus Floor Elevation10.1097/ID.0000000000000618 ↗
17. Impact of mesenchymal stem cells derived conditioned media on neural progenitor cells10.4149/gpb_2021026 ↗
18. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway10.1186/s13287-016-0391-3 ↗
19. The Secretome of Hypoxia Conditioned hMSC Loaded in a Central Depot Induces Chemotaxis and Angiogenesis in a Biomimetic Mineralized Collagen Bone Replacement Material10.1002/adhm.201901426 ↗
20. Rat bone marrow stromal cell-conditioned medium promotes early osseointegration of titanium implants10.11607/jomi.2799 ↗
21. Takeuchi, R., Katagiri, W., Endo, S., and Kobayashi, T. (2019). Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis. PLoS ONE, 14.10.1371/journal.pone.0225472 ↗
22. Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx210.1159/000339245 ↗
23. Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs)10.1016/j.yclnex.2019.01.002 ↗
24. Characterization of conditioned medium of cultured bone marrow stromal cells10.1016/j.neulet.2010.07.062 ↗
25. Thrombin promotes fibronectin secretion by bone marrow mesenchymal stem cells via the protease-activated receptor mediated signalling pathways10.1186/scrt424 ↗
26. Lamora, A., Talbot, J., Mullard, M., Brounais-Le Royer, B., Redini, F., and Verrecchia, F. (2016). TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression. J. Clin. Med., 5.10.3390/jcm5110096 ↗
27. The Role of Hypoxic Mesenchymal Stem Cells Conditioned Medium in Increasing Vascular Endothelial Growth Factors (VEGF) Levels and Collagen Synthesis to Accelerate Wound Healing10.14499/indonesianjcanchemoprev11iss3pp134-143 ↗
28. Medvecky, L., Giretova, M., Stulajterova, R., Luptakova, L., and Sopcak, T. (2021). Tetracalcium Phosphate/Monetite/Calcium Sulfate Hemihdrate Biocement Powder Mixtures Prepared by the One-Step Synthesis for Preparation of Nanocrystalline Hydroxyapatite Biocement-Properties and In Vitro Evaluation. Materials, 14.10.3390/ma14092137 ↗
29. Polyhydroxybutyrate/Chitosan 3D Scaffolds Promote In Vitro and In Vivo Chondrogenesis10.1007/s12010-019-03021-1 ↗
30. (2012). Biological Evaluation of Medical Devices—Part 12: Sample Preparation and Reference Materials (Standard No. ISO 10993-12).
31. (2003). Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity (Standard No. ISO 10993-5).
32. Gene and protein expression profile of naive and osteo-chondrogenically differentiated rat bone marrow-derived mesenchymal progenitor cells
33. Regulation of the secretion of immunoregulatory factors of mesenchymal stem cells (MSCs) by collagen-based scaffolds during chondrogenesis10.1016/j.msec.2016.04.096 ↗
34. Isolation and Characterisation of Mesenchymal Stem Cells from Rat Bone Marrow and the Endosteal Niche: A Comparative Study
35. Characterization of mesenchymal stem cells from rat bone marrow: Ultrastructural properties, differentiation potential and immunophenotypic markers10.1007/s00418-009-0629-6 ↗
36. Comparison of the osteogenic capability of rat bone mesenchymal stem cells on collagen, collagen/hydroxyapatite, hydroxyapatite and biphasic calcium phosphate10.1093/rb/rbx018 ↗
37. Linearization of the bradford protein assay increases its sensitivity: Theoretical and experimental studies10.1006/abio.1996.0171 ↗
38. Tetracalcium phosphate: Synthesis, properties and biomedical applications10.1016/j.actbio.2010.04.020 ↗
39. FT-Raman and high-pressure infrared spectroscopic studies of dicalcium phosphate dehydrate (CaHPO4.2H2O) and anhydrous dicalcium phosphate (CaHPO4)10.1016/S1386-1425(99)00090-6 ↗
40. Spectral properties of Ca-sulfates: Gypsum, bassanite, and anhydrite10.2138/am-2014-4756 ↗
41. Treatment of critical bone defects using calcium phosphate cement and mesoporous bioactive glass providing spatiotemporal drug delivery
42. Conditioned media enhance osteogenic differentiation on poly(L-lactide-co-epsilon-caprolactone)/hydroxyapatite scaffolds and chondrogenic differentiation in alginate10.1163/092050609X12518804794703 ↗
43. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells10.1007/s13770-018-0173-3 ↗
44. Electrostatic attachment of exosome onto a 3D-fabricated calcium silicate/polycaprolactone for enhanced bone regeneration10.1016/j.mtbio.2024.101283 ↗
45. Zhong, Y., Zhang, Y., Yu, A., Zhang, Z., Deng, Z., Xiong, K., Wang, Q., and Zhang, J. (2023). Therapeutic role of exosomes and conditioned medium in keloid and hypertrophic scar and possible mechanisms. Front. Physiol., 14.10.3389/fphys.2023.1247734 ↗
46. Prospect of Stem Cell Conditioned Medium in Regenerative Medicine10.1155/2014/965849 ↗
47. Alkaline phosphatase: Structure, expression and its function in bone mineralization10.1016/j.gene.2020.144855 ↗
48. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture10.1016/j.biomaterials.2005.01.006 ↗
49. Osteonectin bidirectionally regulates osteoblast mineralization10.1186/s13018-023-04250-1 ↗
50. Osteopontin in Bone Metabolism and Bone Diseases10.12659/MSM.919159 ↗
51. Effects of apatite particle size in two apatite/collagen composites on the osteogenic differentiation profile of osteoblastic cells10.3892/ijmm.2013.1516 ↗
52. Mazziotta, C., Lanzillotti, C., Iaquinta, M.R., Taraballi, F., Torreggiani, E., Rotondo, J.C., Otòn-Gonzalez, L., Mazzoni, E., Frontini, F., and Bononi, I. (2021). MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells. Int. J. Mol. Sci., 22.10.3390/ijms22052362 ↗
53. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells10.1038/sj.emboj.7600067 ↗
54. Cell communication and relevant signaling pathways in osteogenesis-angiogenesis coupling10.1038/s41413-025-00417-0 ↗
55. VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes10.3892/ijmm.2016.2502 ↗
56. Carmona-Luque, M., Ballesteros-Ribelles, A., Millán-López, A., Blanco, A., Nogueras, S., and Herrera, C. (2024). The Effect of Cell Culture Passage on the Efficacy of Mesenchymal Stromal Cells as a Cell Therapy Treatment. J. Clin. Med., 13.10.3390/jcm13092480 ↗